FDA approves Roche skin cancer drug Zelboraf
by on Aug.17, 2011, under Health and Fitness
U.S. drug regulators on Wednesday approved a targeted skin cancer drug from Roche Holding along with its diagnostic test, an advance in personalized health care.
View full post on Yahoo! Health News
